Belimumab in childhood systemic lupus erythematosus: A review of available data.

Front Immunol · 2022 · PMC9363663 · PMID 35967351

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

It can be seen that SLE antibodies were improved in varying degrees after BEL and traditional drug treatment in this group, but the difference between two groups did not reach statistical significance ( 10 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.